Drug Information

Drug General Information
Drug ID
D0J6NI
Former ID
DNC011028
Drug Name
4-((1H-Imidazol-4-yl)methyl)-1-phenylpiperidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551227]
Structure
Download
2D MOL

3D MOL
Formula
C15H19N3
Canonical SMILES
C1CN(CCC1CC2=CN=CN2)C3=CC=CC=C3
InChI
1S/C15H19N3/c1-2-4-15(5-3-1)18-8-6-13(7-9-18)10-14-11-16-12-17-14/h1-5,11-13H,6-10H2,(H,16,17)
InChIKey
DKJLGZJEDGFKIC-UHFFFAOYSA-N
PubChem Compound ID
49799252
Target and Pathway
Target(s) Histamine H3 receptor Target Info Inhibitor [551227]
KEGG Pathway Neuroactive ligand-receptor interaction
Reactome Histamine receptors
G alpha (i) signalling events
WikiPathways Monoamine Transport
GPCRs, Class A Rhodopsin-like
GPCR ligand binding
GPCR downstream signaling
References
Ref 551227Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor. Bioorg Med Chem. 2010 Jul 15;18(14):5441-8. doi: 10.1016/j.bmc.2010.04.052. Epub 2010 Apr 21.
Ref 551227Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor. Bioorg Med Chem. 2010 Jul 15;18(14):5441-8. doi: 10.1016/j.bmc.2010.04.052. Epub 2010 Apr 21.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.